Release Date: 19/03/12 09:48 Summary: Reinstatement to Official Quotation: 20/03/2012 Price Sensitive: Yes Download Document 8.5KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%